Work

Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma

Year: 2023

Type: article

Source: Acta Neuropathologica

Authors: A. Basit Khan, Collin W. English, William C. Chen, Prazwal Athukuri, James C. Bayley, Vicky L. Brandt, Arya Shetty, Caroline C. Hadley, Abrar Choudhury, Hsiang-Chih Lu, Arif O. Harmanci, Akdes S. Harmanci, Stephen T. Magill, David R. Raleigh, Tiemo J. Klisch, Akash J. Patel

Institutions: Baylor College of Medicine, University of California, San Francisco, Texas Children's Hospital, The University of Texas Health Science Center at Houston, Northwestern University

Language: English

Topic: Meningioma and schwannoma management

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Conquer Cancer Foundation, Northwestern University, Hamill Foundation, University of California, San Francisco, Robert H. Lurie Comprehensive Cancer Center, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke

Awards: G2190982300, G22827645, G2446292181, G4031201097, Medical Scientist Training Program, G6793263369, G739874040, Understanding druggable drivers of meningioma tumorigenesis

OpenAlex ID: W4318933569

FWCI: 6.518

Cites: 10

Cited by: 39

Related to: 10